ProfileGDS4459 / ENSG00000131055
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 31% 30% 46% 71% 41% 34% 41% 36% 40% 44% 39% 42% 50% 43% 41% 45% 35% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.8131
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.7930
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.1946
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.371
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.0541
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.8234
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.0541
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.8136
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.9840
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.1944
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.9239
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.0542
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.4350
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.1843
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.9841
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.2545
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.8935